Prophylactic antiarrhythmic drug therapy in acute myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D001285:Atropine / Q000627:therapeutic use; D001950:Bretylium Tosylate / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000401:mortality; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D001950:Bretylium Tosylate; D001285:Atropine; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide